Centhaquine

DB16122InvestigationalSmall molecule

Centhaquine is under investigation in clinical trial NCT04045327 (Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock).

Mechanism: Pharmacologically active on Alpha-2A adrenergic receptor and Alpha-2B adrenergic receptor
Curator reviewed
Formula / weight: C₂₂H₂₅N₃ · 331.463 g/mol (avg)
Also known as: Compound-7173
Code names: PMZ-2010

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyUJNWGFBJUHIJKK-UHFFFAOYSA-NSMILESCC1=CC(=CC=C1)N1CCN(CCC2=CC=C3C=CC=CC3=N2)CC1

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 3 drug categories

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Centhaquine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.